AMPLY
To add a bio or update company history, please click update information.
News from AMPLY
AMPLY
11 Feb 2026
AMPLY Discovery secures strategic investment from Keeps Biomed for its AI-led oncology drug discovery solution
AMPLY Discovery applies AI to identify and validate new oncology drug targets. It combines computational analysis with laboratory testing to generate therapeutic programmes for partnering.
AMPLY
1 May 2025
AMPLY raises £1.3m seed led by Twin Path Ventures to accelerate drug discovery for aggressive cancers and superbugs
AMPLY builds an AI driven drug discovery platform that combines computational biology, sequencing and lab validation to develop new treatments for aggressive cancers and drug resistant infections.
AMPLY
- Life Sciences
- Belfast, United Kingdom
- amplydiscovery.com
- Update Information
More venture news
- 17 Mar 2026
Sequential BioSequential secures £2.6m in funding led by Sparkfood and Corundum Systems Biology for non-invasive testing of skin health ingredients
EquityLife Sciences - 16 Mar 2026
Mestag TherapeuticsMestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies
EquityLife Sciences - 16 Mar 2026
Ternary TherapeuticsTernary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines
SeedLife Sciences
